The Good, the Bad and the Ugly
I promised I will fill in the details of Harvey’s experience with Revlimid. It is by no means an “easy” drug, and patients and their doctors need to come up the learning curve on how to use it, what to expect, and how to monitor patients. […]
Archive for March 17th, 2024
This is a publication of
CLL Topics, a patient-run non-profit organization
dedicated to patient education and clinical research in CLL,
(Chronic Lymphocytic Leukemia).
Other Useful Links
- ASBMT
- Clinicaltrials.gov
- CLL PDQ
- Cord Blood Forum
- PubMed
Recent Entries
- Welcome to Harvey’s Journal
- P. C. Venkat, 1949-2008
- Death In The Family
- Knee Deep In Alligators
- A Very Hard Reality to Face
- An Unexpected Left Turn?
- Doldrums
- Springtime!
- Quickie Update
- Eat Your Yogurt
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | ||||||
Archives
Translators
French
German
Spanish
Italian